Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Alexander Zehnder
Malte Greune
Myriam Mendila
Pierre Kemula
Thaminda Ramanayake
Board:
Baron Jean Stéphenne
Debra Stephanie Barker
Klaus Schollmeier
Mathias Hothum
Viola Bronsema
Birgit Hofmann
Craig Tooman
Michael Brosnan
Shareholding in %:
4H invest GmbH 0.45
Bill & Melinda Gates Foundation Trust (Investment Management) 0.71
Camber Capital Management LP 0.78
Deutschland 13.32
Dietmar Hopp 4.59
GSK Plc 7.4
Millennium Management LLC 1.23
RA Capital Management LP 0.88
Zweite DH Verwaltungs GmbH 1.52
dievini Hopp BioTech holding GmbH & Co. KG 31.29
Freefloat 37.84
Address: Friedrich-Miescher-Strasse 15, 72076 Tübingen
T: +49-7071-9883-0
F: +49-7071-9883-1101
I: http://www.curevac.com
E: info@curevac.com